Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

Rhea-AI Summary

Helius Medical Technologies, a neurotech company focused on innovative treatments for balance and gait deficits, has announced its participation in the 2024 ThinkEquity Conference. The event, scheduled for October 30, 2024, will take place at the Mandarin Oriental Hotel in New York.

Helius management will be presenting at 4:30pm ET and conducting one-on-one investor meetings throughout the day. The ThinkEquity Conference is a platform that brings together institutional investors, corporate clients, and industry professionals to showcase groundbreaking innovations and financial strategies.

Interested investors can register to attend the conference and schedule meetings with Helius representatives. This event provides an opportunity for Helius to highlight its novel therapeutic neuromodulation approach and engage with potential investors.

News Market Reaction

-1.82%

1 alert

-1.82% News Effect

On the day this news was published, HSDT declined 1.82%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

NEWTOWN, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (“Helius” or the “Company”) [Nasdaq: HSDT], a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that it plans to participate in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies.

Management will be presenting at 4:30pm ET on October 30^th and holding one-on-one investor meetings throughout the day. Interested investors can register to attend and schedule on-on-one meetings here.

About ThinkEquity
ThinkEquity is a boutique investment bank founded by professionals who have collaborated for over a decade, collectively financing over $50 billion in public and private capital raises, restructurings, and mergers and acquisitions. Past ThinkEquity conferences have featured over 70 company presentations, 700+ attendees, and 500+ one-on-one meetings, providing a valuable platform for companies and investors to connect. To register to attend The ThinkEquity Conference, please follow this link.

About Helius Medical Technologies, Inc.
Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator. For more information about the PoNS^® or Helius Medical Technologies, visit www.heliusmedical.com.

Investor Relations Contact 
Philip Trip Taylor
Gilmartin Group
investorrelations@heliusmedical.com

FAQ

When and where is Helius Medical Technologies (HSDT) presenting at the 2024 ThinkEquity Conference?

Helius Medical Technologies (HSDT) is presenting at the 2024 ThinkEquity Conference on October 30, 2024, at 4:30pm ET. The event is being held at the Mandarin Oriental Hotel in New York.

What opportunities does the 2024 ThinkEquity Conference offer for Helius Medical Technologies (HSDT)?

The 2024 ThinkEquity Conference offers Helius Medical Technologies (HSDT) the opportunity to present their innovative neuromodulation approach, engage in one-on-one investor meetings throughout the day, and connect with institutional investors and industry professionals.

How can investors participate in Helius Medical Technologies' (HSDT) presentation at the 2024 ThinkEquity Conference?

Investors interested in Helius Medical Technologies' (HSDT) presentation at the 2024 ThinkEquity Conference can register to attend the event and schedule one-on-one meetings with the company's management team.

What is the focus of Helius Medical Technologies (HSDT) as presented in the 2024 ThinkEquity Conference announcement?

Helius Medical Technologies (HSDT) is described as a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits.